Patent assignee · US · COMPANY

DCB-USA LLC

16Patents
16Active
16Granted
50Portfolio score

Filing activity: Oct 27, 2008 → May 22, 2018 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9428575B2 Anti-granulysin antibodies and methods of use thereof Chemistry; Metallurgy 5 Active
US10633453B2 Antibody locker for the inactivation of protein drug Chemistry; Metallurgy 2 Active
US7763261B2 Anti-human cytomegalovirus antibodies Chemistry; Metallurgy 1 Active
US9527922B2 Humanized alpha-enolase specific antibodies and methods of uses in cancer therapy Chemistry; Metallurgy 1 Active
US9216950B2 Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same Chemistry; Metallurgy 1 Active
US8119683B2 Aryl substituted sulfonamide compounds and their use as anticancer agents Chemistry; Metallurgy 1 Active
US9315491B2 Pyrimidine compounds as mTOR and PI3K inhibitors Chemistry; Metallurgy 1 Active
US8961971B2 Bispecific T-cell activator antibody Chemistry; Metallurgy 1 Active
US8241608B2 Treating allergy with detoxified E. coli heat-labile enterotoxin Human Necessities 1 Active
US9090617B1 Agonists of Src homology-2 containing protein tyrosine phosphatase-1 and treatment methods using the same Chemistry; Metallurgy 1 Active
US8431118B2 Anti-herpes simplex virus antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US11142567B2 Anti-dengue virus antibody, pharmaceutical composition comprising the same, and uses thereof Emerging Cross-Sectional Technologies 0 Active
US8252906B2 Anti-herpes simplex virus antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US8633252B2 Use of pterosin compounds for treating diabetes and obesity Human Necessities 0 Active
US11202854B2 Disintegrin variants and uses thereof Human Necessities 0 Active
US8895497B2 Cathepsin S inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.